Hawaii 2022 Regular Session

Hawaii Senate Bill SB3141 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	THE SENATE S.B. NO. 3141 THIRTY-FIRST LEGISLATURE, 2022 S.D. 1 STATE OF HAWAII H.D. 2 ~~C.D. 1~~ A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
	1	+	THE SENATE S.B. NO. 3141 THIRTY-FIRST LEGISLATURE, 2022 S.D. 1 STATE OF HAWAII H.D. 2 A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
2	2
3	3		THE SENATE S.B. NO. 3141
4	4		THIRTY-FIRST LEGISLATURE, 2022 S.D. 1
5	5		STATE OF HAWAII H.D. 2
6		-	C.D. 1
7	6
8	7		THE SENATE
9	8
10	9		S.B. NO.
11	10
12	11		3141
13	12
14	13		THIRTY-FIRST LEGISLATURE, 2022
15	14
16	15		S.D. 1
17	16
18	17		STATE OF HAWAII
19	18
20	19		H.D. 2
21	20
22	21
23	22
24		-	~~C.D. 1~~
	23	+
25	24
26	25
27	26
28	27
29	28
30	29
31	30
32	31		A BILL FOR AN ACT
33	32
34	33
35	34
36	35
37	36
38	37		RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
39	38
40	39
41	40
42	41
43	42
44	43		BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
45	44
46	45
47	46
48		-	SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows: 1. By amending subsection (b) to read: "(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); (2) Acetylmethadol; (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), its optical, positional, and geometric isomers, salts, and salts of isomers; (4) Acryl fentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide] (Other name: acryloylfentanyl); (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide); [(3)] (6) Allylprodine; [(4)] (7) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM); [(5)] (8) Alphameprodine; [(6)] (9) Alphamethadol; [(7)] (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine); [(8)] (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); [(9)] (12) Benzethidine; (13) Benzylfentanyl (N-[1-benzyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers; [(10)] (14) Betacetylmethadol; [(11)] (15) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide); [(12)] (16) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide); (17) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide); [(13)] (18) Betameprodine; [(14)] (19) Betamethadol; (20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide) (Other name: [beta]-methyl fentanyl); (21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other names: [beta]'-phenyl fentanyl; 3-phenylpropanoyl fentanyl); [(15)] (22) Betaprodine; (23) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide); [(16)] (24) Clonitazene; (25) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide); [(17)] (26) Dextromoramide; [(18)] (27) Diampromide; [(19)] (28) Diethylthiambutene; [(20)] (29) Difenoxin; [(21)] (30) Dimenoxadol; [(22)] (31) Dimepheptanol; [(23)] (32) Dimethylthiambutene; [(24)] (33) Dioxaphetyl butyrate; [(25)] (34) Dipipanone; [(26)] (35) Ethylmethylthiambutene; [(27)] (36) Etonitazene; [(28)] (37) Etoxeridine; (38) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate); (39) 4-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (Other name: para-fluoroisobutyryl fentanyl); (40) 2'-fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide) (Other name: 2'-fluoro 2-fluorofentanyl); (41) Furanyl fentanyl (N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide); [(29)] (42) Furethidine; [(30)] (43) Hydroxypethidine; [(31)] (44) Ketobemidone; [(32)] (45) Levomoramide; [(33)] (46) Levophenacylmorphan; (47) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (48) 4'-methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide); [(34)] (49) [3-Methylfentanyl] 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); [(35)] (50) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); [(36)] (51) Morpheridine; [(37)] (52) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); [(38)] (53) Noracymethadol; [(39)] (54) Norlevorphanol; [(40)] (55) Normethadone; [(41)] (56) Norpipanone; (57) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide]; (58) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide); (59) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) (Other name: 2-fluorobutyryl fentanyl); (60) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl); (61) Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); (62) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl acetylfentanyl); (63) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl methoxyacetyl fentanyl); (64) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); [(42)] (65) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide; (66) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide); (67) Para-methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 4-methylfentanyl); [(43)] (68) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine[;]); [(44)] (69) Phenadoxone; [(45)] (70) Phenampromide; [(46)] (71) Phenomorphan; [(47)] (72) Phenoperidine; (73) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide) (Other name: benzoyl fentanyl); [(48)] (74) Piritramide; [(49)] (75) Proheptazine; [(50)] (76) Properidine; [(51)] (77) Propiram; [(52)] (78) Racemoramide; (79) Thenylfentanyl (N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers; [(53)] (80) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide); (81) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide) (Other names: 2-thiofuranyl fentanyl; thiophene fentanyl); [(54)] (82) Tilidine; [(55)] (83) Trimeperidine; and [(56) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts, and salts of isomers; (57) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers; (58) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, (acetyl fentanyl), its optical, positional, and geometric isomers, salts, and salts of isomers; (59) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide), its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers; (60) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Butyryl fentanyl); (61) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, its isomers, esters, ethers, salts and salts of isomers, esters, and ethers (Other names: beta-hydroxythiofentanyl); (62) N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Furanyl fentanyl); (63)] (84) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide[, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: U-47700); (64) 4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide]; (65) Acryl fentanyl or acryloylfentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide]; (66) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide]; (67) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide; (68) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (69) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl); and (70) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide])." 2. By amending subsections (f) and (g) to read: "(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Aminorex; (2) Cathinone; (3) 4,4'-dimethylaminorex (common name: 4,4'-DMAR); [(3)] (4) Fenethylline; [(4)] (5) Methcathinone; [(5) N-ethylamphetamine;] (6) 4-methylaminorex; (7) N-ethylamphetamine; [(7)] (8) N,N-dimethylamphetamine; [and] [(8)] (9) Substituted cathinones, any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: (A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; (B) By substitution at the 3-position with an acyclic alkyl substituent; or (C) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. Some other trade names: Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT; Methylenedioxypyrovalerone (MDPV, MDPK); methylone or 3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one, monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC; 3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine, 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e); 2-(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP); 4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone (3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone); alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible[.]; and (10) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (Other names: para-methoxymethamphetamine; PMMA). (g) Any of the following cannabinoids, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Tetrahydrocannabinols; meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; and Delta 3,4 cis or trans-tetrahydrocannabinol, and its optical isomers (since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions, are covered); (2) Naphthoylindoles; meaning any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (3) Naphthylmethylindoles; meaning any compound containing a 1H-indol-3-yl-(1-naphthyl) methane structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (4) Naphthoylpyrroles; meaning any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent; (5) Naphthylmethylindenes; meaning any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent; (6) Phenylacetylindoles; meaning any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent; (7) Cyclohexylphenols; meaning any compound containing a 2-(3-hydroxycyclohexyl) phenol structure with substitution at the 5-position of the phenolic ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not substituted in the cyclohexyl ring to any extent; (8) Benzoylindoles; meaning any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent; (9) [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-naphthalenylmethanone (another trade name is WIN 55,212-2); (10) (6a,10a)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Other trade names are: HU-210/HU-211); (11) Tetramethylcyclopropanoylindoles; meaning any compound containing a 3-tetramethylcyclopropanoylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent; (12) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: APINACA, AKB48); (13) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: PB-22; QUPIC); (14) Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-PB-22; 5F-PB-22); (15) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-FUBINACA); (16) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: ADB-PINACA); (17) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-CHMINACA); (18) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA); (19) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, and geometric isomers, salts, and salts of isomers (Other names: THJ-2201); (20) Methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate, and geometric isomers, salts, and salts of isomers (Other names: FUB-AMB, Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, MMB-FUBINACA, AMB-FUBINACA); (21) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-AMB, 5-fluoro-AMP); (22) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AKB48 N-(5-fluoropentyl) analog, 5F-AKB48, APINACA 5-fluoropentyl analog, 5F-APINACA); (23) N-adamantyl-1-fluoropentylindole-3-Carboxamide, and geometric isomers, salts, and salts of isomers (Other names: STS-135, 5F-APICA; 5-fluoro-APICA); (24) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, and geometric isomers, salts, and salts of isomers (Other names: NM2201[)]; CBL2201); (25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: MAB-CHMINACA and ADB-CHMINACA); (26) Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (Other names: 5F-ADB, 5-flouro-ADB, and 5F-MDMB-PINACA), its optical, positional, and geometric isomers, salts, and salts of isomers; [and] (27) [1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA),] 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers[; also known as] (Other names: SGT-78[, 4-CN-CUMYL-BINACA]; 4-CN-CUMYL BINACA; 4-CN-CUMYL-BUTINACA; CUMYL-CB-PINACA; CUMYL-CYBINACA; [4-cyano CUMYL-BUTINACA.] 4-cyano-CUMYL-BUTINACA; CUMYL-4CN-BINACA); (28) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA); (29) Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA); (30) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other names: 5F-CUMYL-P7AICA); and (31) Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA)." SECTION 2. Section 329-16, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows: "(c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Alfentanil; (2) Alphaprodine; (3) Anileridine; (4) Bezitramide; (5) Bulk Dextropropoxyphene (nondosage form); (6) Carfentanil; (7) Dihydrocodeine; (8) Diphenoxylate; (9) Fentanyl; (10) Isomethadone; (11) Levo-alphacetylmethadol (LAAM); (12) Levomethorphan; (13) Levorphanol; (14) Metazocine; (15) Methadone; (16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane; (17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid; (18) Oliceridine, including the free base form, and its salts, to include the fumarate salt, by definition; [(18)] (19) Pethidine (Meperidine); [(19)] (20) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine; [(20)] (21) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate; [(21)] (22) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid; [(22)] (23) Phenazocine; [(23)] (24) Piminodine; [(24)] (25) Racemethorphan; [(25)] (26) Racemorphan; [(26)] (27) Remifentanil; [(27)] (28) Sufentanil; [(28)] (29) Tapentadol; and [(29)] (30) Thiafentanil." SECTION 3. Section 329-20, Hawaii Revised Statutes, is amended as follows: 1. By amending subsection (b) to read: "(b) Depressants. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, esters, ethers, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, that has a degree of danger or probable danger associated with a depressant effect on the central nervous system: (1) Alprazolam; (2) Barbital; (3) Brexanolone; [(3)] (4) Bromazepam; [(4)] (5) Butorphanol; [(5)] (6) Camazepam; [(6)] (7) Carisoprodol; [(7)] (8) Chloral betaine; [(8)] (9) Chloral hydrate; [(9)] (10) Chlordiazepoxide; [(10)] (11) Clobazam; [(11)] (12) Clonazepam; [(12)] (13) Clorazepate; [(13)] (14) Clotiazepam; [(14)] (15) Cloxazolam; [(15)] (16) Delorazepam; [(16) Dichloralphenazone (Midrin);] (17) Diazepam; (18) Dichloralphenazone (Midrin); [(18)] (19) Estazolam; [(19)] (20) Ethchlorvynol; [(20)] (21) Ethinamate; [(21)] (22) Ethyl loflazepate; [(22)] (23) Fludiazepam; [(23)] (24) Flunitrazepam; [(24)] (25) Flurazepam; [(25)] (26) Fospropofol (Lusedra); [(26)] (27) Halazepam; [(27)] (28) Haloxazolam; [(28)] (29) Ketazolam; (30) Lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide); [(29)] (31) Loprazolam; [(30)] (32) Lorazepam; [(31)] (33) Lormetazepam; [(32)] (34) Mebutamate; [(33)] (35) Medazepam; [(34)] (36) Meprobamate; [(35)] (37) Methohexital; [(36)] (38) Methylphenobarbital (mephorbarbital); [(37)] (39) Midazolam; [(38)] (40) Nimetazepam; [(39)] (41) Nitrazepam; [(40)] (42) Nordiazepam; [(41)] (43) Oxazepam; [(42)] (44) Oxazolam; [(43)] (45) Paraldehyde; [(44)] (46) Petrichloral; [(45)] (47) Phenobarbital; [(46)] (48) Pinazepam; [(47)] (49) Prazepam; [(48)] (50) Quazepam; (51) Remimazolam; [(49)] (52) Suvorexant; [(50)] (53) Temazepam; [(51)] (54) Tetrazepam; [(52)] (55) Triazolam; [(53)] (56) Zaleplon; [(54)] (57) Zolpidem; and [(55)] (58) Zopiclone (Lunesta)[; and (56) Brexanolone]." 2. By amending subsection (d) to read: "(d) Stimulants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (2) Diethylpropion; (3) Fencamfamin; (4) Fenproporex; (5) Lorcaserin; [(5)] (6) Mazindol; [(6)] (7) Mefenorex; [(7)] (8) Modafinil; [(8) Phentermine;] (9) Pemoline (including organometallic complexes and chelates thereof); (10) Phentermine; [(10)] (11) Pipradrol; (12) Serdexmethylphenidate; [(11)] (13) Sibutramine; (14) Solriamfetol; and [(12)] (15) SPA (1-dimethylamino-1,2-diphenylethane, lefetamine)[; (13) Lorcaserin; and (14) Solriamfetol]." SECTION 4. Section 329-22, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows: "(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts; [(1)] (2) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy- propionamide], (Vimpat); (3) Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide); and [(2)] (4) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid][; and (3) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts]." SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored. SECTION 6. This Act shall take effect ~~upon its approval~~.
	47	+	SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows: 1. By amending subsection (b) to read: "(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); (2) Acetylmethadol; (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), its optical, positional, and geometric isomers, salts, and salts of isomers; (4) Acryl fentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide] (Other name: acryloylfentanyl); (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide); [(3)] (6) Allylprodine; [(4)] (7) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM); [(5)] (8) Alphameprodine; [(6)] (9) Alphamethadol; [(7)] (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine); [(8)] (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); [(9)] (12) Benzethidine; (13) Benzylfentanyl (N-[1-benzyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers; [(10)] (14) Betacetylmethadol; [(11)] (15) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide); [(12)] (16) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide); (17) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide); [(13)] (18) Betameprodine; [(14)] (19) Betamethadol; (20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide) (Other name: [beta]-methyl fentanyl); (21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other names: [beta]'-phenyl fentanyl; 3-phenylpropanoyl fentanyl); [(15)] (22) Betaprodine; (23) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide); [(16)] (24) Clonitazene; (25) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide); [(17)] (26) Dextromoramide; [(18)] (27) Diampromide; [(19)] (28) Diethylthiambutene; [(20)] (29) Difenoxin; [(21)] (30) Dimenoxadol; [(22)] (31) Dimepheptanol; [(23)] (32) Dimethylthiambutene; [(24)] (33) Dioxaphetyl butyrate; [(25)] (34) Dipipanone; [(26)] (35) Ethylmethylthiambutene; [(27)] (36) Etonitazene; [(28)] (37) Etoxeridine; (38) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate); (39) 4-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (Other name: para-fluoroisobutyryl fentanyl); (40) 2'-fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide) (Other name: 2'-fluoro 2-fluorofentanyl); (41) Furanyl fentanyl (N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide); [(29)] (42) Furethidine; [(30)] (43) Hydroxypethidine; [(31)] (44) Ketobemidone; [(32)] (45) Levomoramide; [(33)] (46) Levophenacylmorphan; (47) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (48) 4'-methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide); [(34)] (49) [3-Methylfentanyl] 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); [(35)] (50) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); [(36)] (51) Morpheridine; [(37)] (52) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); [(38)] (53) Noracymethadol; [(39)] (54) Norlevorphanol; [(40)] (55) Normethadone; [(41)] (56) Norpipanone; (57) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide]; (58) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide); (59) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) (Other name: 2-fluorobutyryl fentanyl); (60) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl); (61) Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); (62) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl acetylfentanyl); (63) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl methoxyacetyl fentanyl); (64) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); [(42)] (65) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide; (66) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide); (67) Para-methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 4-methylfentanyl); [(43)] (68) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine[;]); [(44)] (69) Phenadoxone; [(45)] (70) Phenampromide; [(46)] (71) Phenomorphan; [(47)] (72) Phenoperidine; (73) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide) (Other name: benzoyl fentanyl); [(48)] (74) Piritramide; [(49)] (75) Proheptazine; [(50)] (76) Properidine; [(51)] (77) Propiram; [(52)] (78) Racemoramide; (79) Thenylfentanyl (N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers; [(53)] (80) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide); (81) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide) (Other names: 2-thiofuranyl fentanyl; thiophene fentanyl); [(54)] (82) Tilidine; [(55)] (83) Trimeperidine; and [(56) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts, and salts of isomers; (57) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers; (58) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, (acetyl fentanyl), its optical, positional, and geometric isomers, salts, and salts of isomers; (59) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide), its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers; (60) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Butyryl fentanyl); (61) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, its isomers, esters, ethers, salts and salts of isomers, esters, and ethers (Other names: beta-hydroxythiofentanyl); (62) N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Furanyl fentanyl); (63)] (84) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide[, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: U-47700); (64) 4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide]; (65) Acryl fentanyl or acryloylfentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide]; (66) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide]; (67) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide; (68) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (69) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl); and (70) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide])." 2. By amending subsections (f) and (g) to read: "(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Aminorex; (2) Cathinone; (3) 4,4'-dimethylaminorex (common name: 4,4'-DMAR); [(3)] (4) Fenethylline; [(4)] (5) Methcathinone; [(5) N-ethylamphetamine;] (6) 4-methylaminorex; (7) N-ethylamphetamine; [(7)] (8) N,N-dimethylamphetamine; [and] [(8)] (9) Substituted cathinones, any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: (A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; (B) By substitution at the 3-position with an acyclic alkyl substituent; or (C) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. Some other trade names: Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT; Methylenedioxypyrovalerone (MDPV, MDPK); methylone or 3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one, monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC; 3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine, 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e); 2-(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP); 4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone (3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone); alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible[.]; and (10) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (Other names: para-methoxymethamphetamine; PMMA). (g) Any of the following cannabinoids, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Tetrahydrocannabinols; meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; and Delta 3,4 cis or trans-tetrahydrocannabinol, and its optical isomers (since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions, are covered); (2) Naphthoylindoles; meaning any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (3) Naphthylmethylindoles; meaning any compound containing a 1H-indol-3-yl-(1-naphthyl) methane structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent; (4) Naphthoylpyrroles; meaning any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent; (5) Naphthylmethylindenes; meaning any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent; (6) Phenylacetylindoles; meaning any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent; (7) Cyclohexylphenols; meaning any compound containing a 2-(3-hydroxycyclohexyl) phenol structure with substitution at the 5-position of the phenolic ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not substituted in the cyclohexyl ring to any extent; (8) Benzoylindoles; meaning any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent; (9) [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-naphthalenylmethanone (another trade name is WIN 55,212-2); (10) (6a,10a)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Other trade names are: HU-210/HU-211); (11) Tetramethylcyclopropanoylindoles; meaning any compound containing a 3-tetramethylcyclopropanoylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent; (12) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: APINACA, AKB48); (13) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: PB-22; QUPIC); (14) Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-PB-22; 5F-PB-22); (15) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-FUBINACA); (16) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: ADB-PINACA); (17) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-CHMINACA); (18) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA); (19) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, and geometric isomers, salts, and salts of isomers (Other names: THJ-2201); (20) Methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate, and geometric isomers, salts, and salts of isomers (Other names: FUB-AMB, Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, MMB-FUBINACA, AMB-FUBINACA); (21) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-AMB, 5-fluoro-AMP); (22) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AKB48 N-(5-fluoropentyl) analog, 5F-AKB48, APINACA 5-fluoropentyl analog, 5F-APINACA); (23) N-adamantyl-1-fluoropentylindole-3-Carboxamide, and geometric isomers, salts, and salts of isomers (Other names: STS-135, 5F-APICA; 5-fluoro-APICA); (24) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, and geometric isomers, salts, and salts of isomers (Other names: NM2201[)]; CBL2201); (25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: MAB-CHMINACA and ADB-CHMINACA); (26) Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (Other names: 5F-ADB, 5-flouro-ADB, and 5F-MDMB-PINACA), its optical, positional, and geometric isomers, salts, and salts of isomers; [and] (27) [1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA),] 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers[; also known as] (Other names: SGT-78[, 4-CN-CUMYL-BINACA]; 4-CN-CUMYL BINACA; 4-CN-CUMYL-BUTINACA; CUMYL-CB-PINACA; CUMYL-CYBINACA; [4-cyano CUMYL-BUTINACA.] 4-cyano-CUMYL-BUTINACA; CUMYL-4CN-BINACA); (28) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA); (29) Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA); (30) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other names: 5F-CUMYL-P7AICA); and (31) Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA)." SECTION 2. Section 329-16, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows: "(c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Alfentanil; (2) Alphaprodine; (3) Anileridine; (4) Bezitramide; (5) Bulk Dextropropoxyphene (nondosage form); (6) Carfentanil; (7) Dihydrocodeine; (8) Diphenoxylate; (9) Fentanyl; (10) Isomethadone; (11) Levo-alphacetylmethadol (LAAM); (12) Levomethorphan; (13) Levorphanol; (14) Metazocine; (15) Methadone; (16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane; (17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid; (18) Oliceridine, including the free base form, and its salts, to include the fumarate salt, by definition; [(18)] (19) Pethidine (Meperidine); [(19)] (20) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine; [(20)] (21) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate; [(21)] (22) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid; [(22)] (23) Phenazocine; [(23)] (24) Piminodine; [(24)] (25) Racemethorphan; [(25)] (26) Racemorphan; [(26)] (27) Remifentanil; [(27)] (28) Sufentanil; [(28)] (29) Tapentadol; and [(29)] (30) Thiafentanil." SECTION 3. Section 329-20, Hawaii Revised Statutes, is amended as follows: 1. By amending subsection (b) to read: "(b) Depressants. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, esters, ethers, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, that has a degree of danger or probable danger associated with a depressant effect on the central nervous system: (1) Alprazolam; (2) Barbital; (3) Brexanolone; [(3)] (4) Bromazepam; [(4)] (5) Butorphanol; [(5)] (6) Camazepam; [(6)] (7) Carisoprodol; [(7)] (8) Chloral betaine; [(8)] (9) Chloral hydrate; [(9)] (10) Chlordiazepoxide; [(10)] (11) Clobazam; [(11)] (12) Clonazepam; [(12)] (13) Clorazepate; [(13)] (14) Clotiazepam; [(14)] (15) Cloxazolam; [(15)] (16) Delorazepam; [(16) Dichloralphenazone (Midrin);] (17) Diazepam; (18) Dichloralphenazone (Midrin); [(18)] (19) Estazolam; [(19)] (20) Ethchlorvynol; [(20)] (21) Ethinamate; [(21)] (22) Ethyl loflazepate; [(22)] (23) Fludiazepam; [(23)] (24) Flunitrazepam; [(24)] (25) Flurazepam; [(25)] (26) Fospropofol (Lusedra); [(26)] (27) Halazepam; [(27)] (28) Haloxazolam; [(28)] (29) Ketazolam; (30) Lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide); [(29)] (31) Loprazolam; [(30)] (32) Lorazepam; [(31)] (33) Lormetazepam; [(32)] (34) Mebutamate; [(33)] (35) Medazepam; [(34)] (36) Meprobamate; [(35)] (37) Methohexital; [(36)] (38) Methylphenobarbital (mephorbarbital); [(37)] (39) Midazolam; [(38)] (40) Nimetazepam; [(39)] (41) Nitrazepam; [(40)] (42) Nordiazepam; [(41)] (43) Oxazepam; [(42)] (44) Oxazolam; [(43)] (45) Paraldehyde; [(44)] (46) Petrichloral; [(45)] (47) Phenobarbital; [(46)] (48) Pinazepam; [(47)] (49) Prazepam; [(48)] (50) Quazepam; (51) Remimazolam; [(49)] (52) Suvorexant; [(50)] (53) Temazepam; [(51)] (54) Tetrazepam; [(52)] (55) Triazolam; [(53)] (56) Zaleplon; [(54)] (57) Zolpidem; and [(55)] (58) Zopiclone (Lunesta)[; and (56) Brexanolone]." 2. By amending subsection (d) to read: "(d) Stimulants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (2) Diethylpropion; (3) Fencamfamin; (4) Fenproporex; (5) Lorcaserin; [(5)] (6) Mazindol; [(6)] (7) Mefenorex; [(7)] (8) Modafinil; [(8) Phentermine;] (9) Pemoline (including organometallic complexes and chelates thereof); (10) Phentermine; [(10)] (11) Pipradrol; (12) Serdexmethylphenidate; [(11)] (13) Sibutramine; (14) Solriamfetol; and [(12)] (15) SPA (1-dimethylamino-1,2-diphenylethane, lefetamine)[; (13) Lorcaserin; and (14) Solriamfetol]." SECTION 4. Section 329-22, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows: "(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts; [(1)] (2) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy- propionamide], (Vimpat); (3) Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide); and [(2)] (4) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid][; and (3) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts]." SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored. SECTION 6. This Act shall take effect on January 1, 2050.
49	48
50	49		SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows:
51	50
52	51		1. By amending subsection (b) to read:
53	52
54	53		"(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
55	54
56	55		(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
57	56
58	57		(2) Acetylmethadol;
59	58
60	59		(3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), its optical, positional, and geometric isomers, salts, and salts of isomers;
61	60
62	61		(4) Acryl fentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide] (Other name: acryloylfentanyl);
63	62
64	63		(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide);
65	64
66	65		[(3)] (6) Allylprodine;
67	66
68	67		[(4)] (7) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM);
69	68
70	69		[(5)] (8) Alphameprodine;
71	70
72	71		[(6)] (9) Alphamethadol;
73	72
74	73		[(7)] (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);
75	74
76	75		[(8)] (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
77	76
78	77		[(9)] (12) Benzethidine;
79	78
80	79		(13) Benzylfentanyl (N-[1-benzyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers;
81	80
82	81		[(10)] (14) Betacetylmethadol;
83	82
84	83		[(11)] (15) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
85	84
86	85		[(12)] (16) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
87	86
88	87		(17) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);
89	88
90	89		[(13)] (18) Betameprodine;
91	90
92	91		[(14)] (19) Betamethadol;
93	92
94	93		(20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide) (Other name: [beta]-methyl fentanyl);
95	94
96	95		(21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other names: [beta]'-phenyl fentanyl; 3-phenylpropanoyl fentanyl);
97	96
98	97		[(15)] (22) Betaprodine;
99	98
100	99		(23) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);
101	100
102	101		[(16)] (24) Clonitazene;
103	102
104	103		(25) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
105	104
106	105		[(17)] (26) Dextromoramide;
107	106
108	107		[(18)] (27) Diampromide;
109	108
110	109		[(19)] (28) Diethylthiambutene;
111	110
112	111		[(20)] (29) Difenoxin;
113	112
114	113		[(21)] (30) Dimenoxadol;
115	114
116	115		[(22)] (31) Dimepheptanol;
117	116
118	117		[(23)] (32) Dimethylthiambutene;
119	118
120	119		[(24)] (33) Dioxaphetyl butyrate;
121	120
122	121		[(25)] (34) Dipipanone;
123	122
124	123		[(26)] (35) Ethylmethylthiambutene;
125	124
126	125		[(27)] (36) Etonitazene;
127	126
128	127		[(28)] (37) Etoxeridine;
129	128
130	129		(38) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate);
131	130
132	131		(39) 4-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (Other name: para-fluoroisobutyryl fentanyl);
133	132
134	133		(40) 2'-fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide) (Other name: 2'-fluoro 2-fluorofentanyl);
135	134
136	135		(41) Furanyl fentanyl (N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide);
137	136
138	137		[(29)] (42) Furethidine;
139	138
140	139		[(30)] (43) Hydroxypethidine;
141	140
142	141		[(31)] (44) Ketobemidone;
143	142
144	143		[(32)] (45) Levomoramide;
145	144
146	145		[(33)] (46) Levophenacylmorphan;
147	146
148	147		(47) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
149	148
150	149		(48) 4'-methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide);
151	150
152	151		[(34)] (49) [3-Methylfentanyl] 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
153	152
154	153		[(35)] (50) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
155	154
156	155		[(36)] (51) Morpheridine;
157	156
158	157		[(37)] (52) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
159	158
160	159		[(38)] (53) Noracymethadol;
161	160
162	161		[(39)] (54) Norlevorphanol;
163	162
164	163		[(40)] (55) Normethadone;
165	164
166	165		[(41)] (56) Norpipanone;
167	166
168	167		(57) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide];
169	168
170	169		(58) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide);
171	170
172	171		(59) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) (Other name: 2-fluorobutyryl fentanyl);
173	172
174	173		(60) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl);
175	174
176	175		(61) Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
177	176
178	177		(62) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl acetylfentanyl);
179	178
180	179		(63) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl methoxyacetyl fentanyl);
181	180
182	181		(64) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
183	182
184	183		[(42)] (65) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide;
185	184
186	185		(66) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
187	186
188	187		(67) Para-methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 4-methylfentanyl);
189	188
190	189		[(43)] (68) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine[;]);
191	190
192	191		[(44)] (69) Phenadoxone;
193	192
194	193		[(45)] (70) Phenampromide;
195	194
196	195		[(46)] (71) Phenomorphan;
197	196
198	197		[(47)] (72) Phenoperidine;
199	198
200	199		(73) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide) (Other name: benzoyl fentanyl);
201	200
202	201		[(48)] (74) Piritramide;
203	202
204	203		[(49)] (75) Proheptazine;
205	204
206	205		[(50)] (76) Properidine;
207	206
208	207		[(51)] (77) Propiram;
209	208
210	209		[(52)] (78) Racemoramide;
211	210
212	211		(79) Thenylfentanyl (N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers;
213	212
214	213		[(53)] (80) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
215	214
216	215		(81) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide) (Other names: 2-thiofuranyl fentanyl; thiophene fentanyl);
217	216
218	217		[(54)] (82) Tilidine;
219	218
220	219		[(55)] (83) Trimeperidine; and
221	220
222	221		[(56) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts, and salts of isomers;
223	222
224	223		(57) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers;
225	224
226	225		(58) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, (acetyl fentanyl), its optical, positional, and geometric isomers, salts, and salts of isomers;
227	226
228	227		(59) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide), its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;
229	228
230	229		(60) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Butyryl fentanyl);
231	230
232	231		(61) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, its isomers, esters, ethers, salts and salts of isomers, esters, and ethers (Other names: beta-hydroxythiofentanyl);
233	232
234	233		(62) N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: Furanyl fentanyl);
235	234
236	235		(63)] (84) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide[, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: U-47700);
237	236
238	237		(64) 4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide];
239	238
240	239		(65) Acryl fentanyl or acryloylfentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide];
241	240
242	241		(66) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide];
243	242
244	243		(67) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide;
245	244
246	245		(68) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
247	246
248	247		(69) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl); and
249	248
250	249		(70) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide])."
251	250
252	251		2. By amending subsections (f) and (g) to read:
253	252
254	253		"(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
255	254
256	255		(1) Aminorex;
257	256
258	257		(2) Cathinone;
259	258
260	259		(3) 4,4'-dimethylaminorex (common name: 4,4'-DMAR);
261	260
262	261		[(3)] (4) Fenethylline;
263	262
264	263		[(4)] (5) Methcathinone;
265	264
266	265		[(5) N-ethylamphetamine;]
267	266
268	267		(6) 4-methylaminorex;
269	268
270	269		(7) N-ethylamphetamine;
271	270
272	271		[(7)] (8) N,N-dimethylamphetamine; [and]
273	272
274	273		[(8)] (9) Substituted cathinones, any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways:
275	274
276	275		(A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
277	276
278	277		(B) By substitution at the 3-position with an acyclic alkyl substituent; or
279	278
280	279		(C) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.
281	280
282	281		Some other trade names: Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT; Methylenedioxypyrovalerone (MDPV, MDPK); methylone or 3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one, monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC; 3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine, 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e); 2-(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP); 4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone (3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone); alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible[.]; and
283	282
284	283		(10) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (Other names: para-methoxymethamphetamine; PMMA).
285	284
286	285		(g) Any of the following cannabinoids, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
287	286
288	287		(1) Tetrahydrocannabinols; meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; and Delta 3,4 cis or trans-tetrahydrocannabinol, and its optical isomers (since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions, are covered);
289	288
290	289		(2) Naphthoylindoles; meaning any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent;
291	290
292	291		(3) Naphthylmethylindoles; meaning any compound containing a 1H-indol-3-yl-(1-naphthyl) methane structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent;
293	292
294	293		(4) Naphthoylpyrroles; meaning any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;
295	294
296	295		(5) Naphthylmethylindenes; meaning any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;
297	296
298	297		(6) Phenylacetylindoles; meaning any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent;
299	298
300	299		(7) Cyclohexylphenols; meaning any compound containing a 2-(3-hydroxycyclohexyl) phenol structure with substitution at the 5-position of the phenolic ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not substituted in the cyclohexyl ring to any extent;
301	300
302	301		(8) Benzoylindoles; meaning any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent;
303	302
304	303		(9) [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-naphthalenylmethanone (another trade name is WIN 55,212-2);
305	304
306	305		(10) (6a,10a)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Other trade names are: HU-210/HU-211);
307	306
308	307		(11) Tetramethylcyclopropanoylindoles; meaning any compound containing a 3-tetramethylcyclopropanoylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent;
309	308
310	309		(12) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: APINACA, AKB48);
311	310
312	311		(13) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: PB-22; QUPIC);
313	312
314	313		(14) Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-PB-22; 5F-PB-22);
315	314
316	315		(15) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-FUBINACA);
317	316
318	317		(16) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: ADB-PINACA);
319	318
320	319		(17) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-CHMINACA);
321	320
322	321		(18) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA);
323	322
324	323		(19) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, and geometric isomers, salts, and salts of isomers (Other names: THJ-2201);
325	324
326	325		(20) Methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate, and geometric isomers, salts, and salts of isomers (Other names: FUB-AMB, Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, MMB-FUBINACA, AMB-FUBINACA);
327	326
328	327		(21) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, and geometric isomers, salts, and salts of isomers (Other names: 5-fluoro-AMB, 5-fluoro-AMP);
329	328
330	329		(22) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: AKB48 N-(5-fluoropentyl) analog, 5F-AKB48, APINACA 5-fluoropentyl analog, 5F-APINACA);
331	330
332	331		(23) N-adamantyl-1-fluoropentylindole-3-Carboxamide, and geometric isomers, salts, and salts of isomers (Other names: STS-135, 5F-APICA; 5-fluoro-APICA);
333	332
334	333		(24) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, and geometric isomers, salts, and salts of isomers (Other names: NM2201[)]; CBL2201);
335	334
336	335		(25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names: MAB-CHMINACA and ADB-CHMINACA);
337	336
338	337		(26) Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (Other names: 5F-ADB, 5-flouro-ADB, and 5F-MDMB-PINACA), its optical, positional, and geometric isomers, salts, and salts of isomers; [and]
339	338
340	339		(27) [1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA),] 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers[; also known as] (Other names: SGT-78[, 4-CN-CUMYL-BINACA]; 4-CN-CUMYL BINACA; 4-CN-CUMYL-BUTINACA; CUMYL-CB-PINACA; CUMYL-CYBINACA; [4-cyano CUMYL-BUTINACA.] 4-cyano-CUMYL-BUTINACA; CUMYL-4CN-BINACA);
341	340
342	341		(28) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA);
343	342
344	343		(29) Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA);
345	344
346	345		(30) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other names: 5F-CUMYL-P7AICA); and
347	346
348	347		(31) Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA)."
349	348
350	349		SECTION 2. Section 329-16, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:
351	350
352	351		"(c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
353	352
354	353		(1) Alfentanil;
355	354
356	355		(2) Alphaprodine;
357	356
358	357		(3) Anileridine;
359	358
360	359		(4) Bezitramide;
361	360
362	361		(5) Bulk Dextropropoxyphene (nondosage form);
363	362
364	363		(6) Carfentanil;
365	364
366	365		(7) Dihydrocodeine;
367	366
368	367		(8) Diphenoxylate;
369	368
370	369		(9) Fentanyl;
371	370
372	371		(10) Isomethadone;
373	372
374	373		(11) Levo-alphacetylmethadol (LAAM);
375	374
376	375		(12) Levomethorphan;
377	376
378	377		(13) Levorphanol;
379	378
380	379		(14) Metazocine;
381	380
382	381		(15) Methadone;
383	382
384	383		(16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
385	384
386	385		(17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid;
387	386
388	387		(18) Oliceridine, including the free base form, and its salts, to include the fumarate salt, by definition;
389	388
390	389		[(18)] (19) Pethidine (Meperidine);
391	390
392	391		[(19)] (20) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
393	392
394	393		[(20)] (21) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
395	394
396	395		[(21)] (22) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
397	396
398	397		[(22)] (23) Phenazocine;
399	398
400	399		[(23)] (24) Piminodine;
401	400
402	401		[(24)] (25) Racemethorphan;
403	402
404	403		[(25)] (26) Racemorphan;
405	404
406	405		[(26)] (27) Remifentanil;
407	406
408	407		[(27)] (28) Sufentanil;
409	408
410	409		[(28)] (29) Tapentadol; and
411	410
412	411		[(29)] (30) Thiafentanil."
413	412
414	413		SECTION 3. Section 329-20, Hawaii Revised Statutes, is amended as follows:
415	414
416	415		1. By amending subsection (b) to read:
417	416
418	417		"(b) Depressants. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, esters, ethers, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, that has a degree of danger or probable danger associated with a depressant effect on the central nervous system:
419	418
420	419		(1) Alprazolam;
421	420
422	421		(2) Barbital;
423	422
424	423		(3) Brexanolone;
425	424
426	425		[(3)] (4) Bromazepam;
427	426
428	427		[(4)] (5) Butorphanol;
429	428
430	429		[(5)] (6) Camazepam;
431	430
432	431		[(6)] (7) Carisoprodol;
433	432
434	433		[(7)] (8) Chloral betaine;
435	434
436	435		[(8)] (9) Chloral hydrate;
437	436
438	437		[(9)] (10) Chlordiazepoxide;
439	438
440	439		[(10)] (11) Clobazam;
441	440
442	441		[(11)] (12) Clonazepam;
443	442
444	443		[(12)] (13) Clorazepate;
445	444
446	445		[(13)] (14) Clotiazepam;
447	446
448	447		[(14)] (15) Cloxazolam;
449	448
450	449		[(15)] (16) Delorazepam;
451	450
452	451		[(16) Dichloralphenazone (Midrin);]
453	452
454	453		(17) Diazepam;
455	454
456	455		(18) Dichloralphenazone (Midrin);
457	456
458	457		[(18)] (19) Estazolam;
459	458
460	459		[(19)] (20) Ethchlorvynol;
461	460
462	461		[(20)] (21) Ethinamate;
463	462
464	463		[(21)] (22) Ethyl loflazepate;
465	464
466	465		[(22)] (23) Fludiazepam;
467	466
468	467		[(23)] (24) Flunitrazepam;
469	468
470	469		[(24)] (25) Flurazepam;
471	470
472	471		[(25)] (26) Fospropofol (Lusedra);
473	472
474	473		[(26)] (27) Halazepam;
475	474
476	475		[(27)] (28) Haloxazolam;
477	476
478	477		[(28)] (29) Ketazolam;
479	478
480	479		(30) Lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide);
481	480
482	481		[(29)] (31) Loprazolam;
483	482
484	483		[(30)] (32) Lorazepam;
485	484
486	485		[(31)] (33) Lormetazepam;
487	486
488	487		[(32)] (34) Mebutamate;
489	488
490	489		[(33)] (35) Medazepam;
491	490
492	491		[(34)] (36) Meprobamate;
493	492
494	493		[(35)] (37) Methohexital;
495	494
496	495		[(36)] (38) Methylphenobarbital (mephorbarbital);
497	496
498	497		[(37)] (39) Midazolam;
499	498
500	499		[(38)] (40) Nimetazepam;
501	500
502	501		[(39)] (41) Nitrazepam;
503	502
504	503		[(40)] (42) Nordiazepam;
505	504
506	505		[(41)] (43) Oxazepam;
507	506
508	507		[(42)] (44) Oxazolam;
509	508
510	509		[(43)] (45) Paraldehyde;
511	510
512	511		[(44)] (46) Petrichloral;
513	512
514	513		[(45)] (47) Phenobarbital;
515	514
516	515		[(46)] (48) Pinazepam;
517	516
518	517		[(47)] (49) Prazepam;
519	518
520	519		[(48)] (50) Quazepam;
521	520
522	521		(51) Remimazolam;
523	522
524	523		[(49)] (52) Suvorexant;
525	524
526	525		[(50)] (53) Temazepam;
527	526
528	527		[(51)] (54) Tetrazepam;
529	528
530	529		[(52)] (55) Triazolam;
531	530
532	531		[(53)] (56) Zaleplon;
533	532
534	533		[(54)] (57) Zolpidem; and
535	534
536	535		[(55)] (58) Zopiclone (Lunesta)[; and
537	536
538	537		(56) Brexanolone]."
539	538
540	539		2. By amending subsection (d) to read:
541	540
542	541		"(d) Stimulants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
543	542
544	543		(1) Cathine ((+)-norpseudoephedrine);
545	544
546	545		(2) Diethylpropion;
547	546
548	547		(3) Fencamfamin;
549	548
550	549		(4) Fenproporex;
551	550
552	551		(5) Lorcaserin;
553	552
554	553		[(5)] (6) Mazindol;
555	554
556	555		[(6)] (7) Mefenorex;
557	556
558	557		[(7)] (8) Modafinil;
559	558
560	559		[(8) Phentermine;]
561	560
562	561		(9) Pemoline (including organometallic complexes and chelates thereof);
563	562
564	563		(10) Phentermine;
565	564
566	565		[(10)] (11) Pipradrol;
567	566
568	567		(12) Serdexmethylphenidate;
569	568
570	569		[(11)] (13) Sibutramine;
571	570
572	571		(14) Solriamfetol; and
573	572
574	573		[(12)] (15) SPA (1-dimethylamino-1,2-diphenylethane, lefetamine)[;
575	574
576	575		(13) Lorcaserin; and
577	576
578	577		(14) Solriamfetol]."
579	578
580	579		SECTION 4. Section 329-22, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows:
581	580
582	581		"(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:
583	582
584	583		(1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts;
585	584
586	585		[(1)] (2) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy- propionamide], (Vimpat);
587	586
588	587		(3) Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide); and
589	588
590	589		[(2)] (4) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid][; and
591	590
592	591		(3) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts]."
593	592
594	593		SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
595	594
596		-	SECTION 6. This Act shall take effect ~~upon its approval~~.
	595	+	SECTION 6. This Act shall take effect on January 1, 2050.
597	596
598		-	Report Title: Uniform Controlled Substances Act Description: Amends the schedules for controlled substances under the Uniform Controlled Substances Act for purposes of conforming with updates in federal law. (~~CD1~~) The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
	597	+	Report Title: Uniform Controlled Substances Act Description: Amends the schedules for controlled substances under the Uniform Controlled Substances Act for purposes of conforming with updates in federal law. Effective 1/1/2050. (HD2) The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
599	598
600	599
601	600
602	601
603	602
604	603		Report Title:
605	604
606	605		Uniform Controlled Substances Act
607	606
608	607
609	608
610	609		Description:
611	610
612		-	Amends the schedules for controlled substances under the Uniform Controlled Substances Act for purposes of conforming with updates in federal law. (~~CD1~~)
	611	+	Amends the schedules for controlled substances under the Uniform Controlled Substances Act for purposes of conforming with updates in federal law. Effective 1/1/2050. (HD2)
613	612
614	613
615	614
616	615
617	616
618	617
619	618
620	619		The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.